Author Correction: Topical application of an irreversible small molecule inhibitor of lysyl oxidases ameliorates skin scarring and fibrosis

Affiliations

• ¹ Burn Injury Research Unit, School of Biomedical Sciences, The University of Western Australia, Crawley, Australia.
• ² School of Molecular Sciences, The University of Western Australia, Crawley, Australia.
• ³ Drug Discovery Department, Pharmaxis Ltd, Sydney, NSW, Australia.
• ⁴ School of Polymer Science and Engineering, University of Southern Mississippi, Hattiesburg, MS, 39406, USA.
• ⁵ Intelligent Polymer Research Institute, Australian Research Council Centre of Excellence for Electromaterials Science, University of Wollongong, Wollongong, NSW, 2500, Australia.
• ⁶ Australian National Fabrication Facility-Materials Node, Innovation Campus, University of Wollongong, Wollongong, NSW, 2500, Australia.
• ⁷ Burns Service of Western Australia, WA, Department of Health, Nedlands, WA, Australia.
• ⁸ Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
• ⁹ School of Pharmacy and Biomedical Sciences, Curtin University, Bentley, WA, Australia.
• ¹⁰ School of Global Population Health, University of Western Australia, Crawley, Australia.
• ¹¹ Burn Injury Research Unit, School of Biomedical Sciences, The University of Western Australia, Crawley, Australia. mark.fear@uwa.edu.au.